Glowing protected cell in a translucent teal sphere with warm gold light, symbolizing safety and eligibility standards of our autism treatment programs.

Safety & Eligibility

Patient safety first

Patient safety is the foundation of everything we do. Every child is carefully evaluated for suitability, and rigorous safety protocols protect them before, during and after treatment.

Countries Served
40+Countries Served
Certified MSC Sourcing
GMPCertified MSC Sourcing
Personalised Protocols
1:1Personalised Protocols
Multilingual Coordination
EN/TRMultilingual Coordination

Not every child is a candidate for regenerative medicine — and that is a feature of safe practice, not a limitation. Honest eligibility assessment protects the families we treat and the families we decline.

Safety Profile of MSC Therapy

Mesenchymal stem cells from Wharton's Jelly (umbilical cord tissue) have a favourable safety profile documented in numerous published studies and clinical trials.

  • Immunological privilege — no donor-recipient matching is required
  • Low risk of immune rejection or adverse reactions
  • No tumorigenic potential documented in clinical use
  • Extensive clinical experience across multiple medical applications

Eligibility Assessment

Our eligibility assessment process includes a comprehensive review of medical history, evaluation of current health status, assessment of any contraindications, review of current medications and treatments, and a discussion of family expectations and goals.

Children with certain active medical conditions, uncontrolled infections or specific contraindications may not be suitable candidates. Our medical team discusses eligibility honestly and will not recommend treatment if it is not appropriate.

During Treatment

Safety during treatment is maintained through careful cell preparation and quality verification before every procedure, experienced medical staff performing every step, continuous monitoring during and after administration, on-standby emergency protocols and equipment, and age-appropriate pain management and comfort measures.

After Treatment

Post-treatment safety monitoring includes observation during the remainder of your stay, detailed discharge instructions for home care, structured follow-up consultations to monitor for delayed effects, and ongoing access to our medical team for questions or concerns.

Speak with our team

Have questions about whether this is right for your child?

Our medical coordinators reply within 24 hours. No pressure, no commitment — just an honest conversation about your child and what we may (or may not) be able to offer.

Eligibility review process

How a candidate is evaluated

Six structured steps that determine whether our protocols are appropriate for a specific child.

  1. Initial inquiry

    Family submits a brief overview of the child's age, diagnosis and main concerns.

  2. Medical records review

    Diagnostic reports, developmental assessments and laboratory results are reviewed by our medical team.

  3. Contraindication screening

    Active infections, uncontrolled conditions and specific contraindications are explicitly checked.

  4. Medication review

    Current medications and existing therapies are evaluated for interaction and timing considerations.

  5. Goals & expectations conversation

    An honest discussion with the family clarifies what is — and is not — realistic.

  6. Recommendation or decline

    A written recommendation is issued, or treatment is respectfully declined when not appropriate.

Verified Credentials

Medical Governance & Accreditation

Republic of Türkiye Ministry of Health

Clinics operate under formal Ministry of Health licensing and inspection — the national regulator for all medical practice in Türkiye.

GMP-Certified Cell Sourcing

MSC and exosome products are sourced from Good Manufacturing Practice laboratories with full batch certificates of analysis.

Turkish Medical Association

Treating physicians are registered members of the Turkish Medical Association (Türk Tabipleri Birliği) and bound by its professional code.

ISO-Aligned Clinical Standards

Facilities follow internationally aligned ISO 9001-style processes for hygiene, equipment maintenance, and emergency preparedness.

Credentials referenced on this page are verified against issuing institutions and re-checked annually as part of our editorial standards.

Safety & Eligibility — Frequently Asked Questions

Active uncontrolled infections, certain oncological histories, severe uncontrolled medical conditions, and specific contraindications identified during medical review may make treatment inappropriate. The full list is reviewed case-by-case.

We evaluate candidates from a wide paediatric age range. Suitability is determined by the child's overall health and clinical profile rather than age alone.

MSC therapy from Wharton's Jelly has a favourable safety profile. Mild, transient effects (low-grade fever, fatigue) are uncommon but possible. Serious adverse events are rare in published clinical experience.

Yes. Comprehensive informed consent — covering benefits, limitations, risks and alternatives — is obtained from parents/legal guardians before any procedure.

If our medical team determines that treatment is not appropriate, we say so clearly and explain why. Where relevant, we suggest alternative directions to discuss with your local clinicians.

Ready to Explore Treatment Options?

Request a free consultation with our medical coordination team. We'll review your child's case and provide personalized guidance.

Chat with us on WhatsApp